Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eurofins Scientific | Paris | Healthcare | Biotechnology & Medical Research | €11.26B | 33.3x | 0.73 | €58.54 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -6.4% Downside | Upgrade to Pro+ | |
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €455.43M | -5x | 0.03 | €2.67 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €431.37M | -2.3x | -0.15 | €6.77 | -8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €417.66M | -1x | 0.08 | €3 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €251.36M | 64.2x | -6.44 | €25.05 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.2% Upside | Upgrade to Pro+ | |
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €194.83M | -2.8x | 0.08 | €4.10 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €176.53M | 125.3x | 1.25 | €3.78 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €168.63M | -3.1x | 0.01 | €1.89 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene | Paris | Healthcare | Biotechnology & Medical Research | €133.25M | -3.5x | 0.13 | €1.01 | 6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.6% Upside | Upgrade to Pro+ | |
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €124.92M | 3.2x | 0.02 | €5.52 | -6.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €122.30M | -4.5x | -0.09 | €0.41 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurofins-Cerep | Paris | Healthcare | Biotechnology & Medical Research | €103.91M | €20,600 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €93.25M | -2.4x | -0.03 | €1.29 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €88.46M | -2.7x | 0.1 | €5.42 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adocia | Paris | Healthcare | Biotechnology & Medical Research | €62.98M | -5.5x | -0.1 | €3.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fermentalg | Paris | Healthcare | Biotechnology & Medical Research | €47.37M | -3.1x | -0.08 | €0.53 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.2% Upside | Upgrade to Pro+ | |
Abionyx Pharma SA | Paris | Healthcare | Biotechnology & Medical Research | €44.39M | -9.9x | 1.23 | €1.28 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Novacyt | Paris | Healthcare | Biotechnology & Medical Research | €38.94M | -0.9x | 0.02 | €0.55 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Poxel SA | Paris | Healthcare | Biotechnology & Medical Research | €37.03M | -1.7x | -0.04 | €0.69 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genoway | Paris | Healthcare | Biotechnology & Medical Research | €31.44M | €3.41 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Gensight Biologics | Paris | Healthcare | Biotechnology & Medical Research | €26.02M | -1.4x | -0.03 | €0.20 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NFL Biosciences | Paris | Healthcare | Biotechnology & Medical Research | €14.80M | -6.4x | -0.11 | €1.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Predilife | Paris | Healthcare | Biotechnology & Medical Research | €14.63M | -3.1x | 0.18 | €3.91 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valbiotis | Paris | Healthcare | Biotechnology & Medical Research | €14.06M | -1.4x | 0.25 | €0.90 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Plant Advanced Technologies SA | Paris | Healthcare | Biotechnology & Medical Research | €11.66M | €10.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
TME Pharma NV | Paris | Healthcare | Biotechnology & Medical Research | €8.16M | -0.5x | -0.02 | €0.09 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Theranexus | Paris | Healthcare | Biotechnology & Medical Research | €7.72M | -4.4x | -0.06 | €0.92 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncodesign Precision Medicine | Paris | Healthcare | Biotechnology & Medical Research | €6M | -0.9x | -0.05 | €0.32 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum Genomics SA | Paris | Healthcare | Biotechnology & Medical Research | €5.03M | -3.6x | -0.01 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
Integragen | Paris | Healthcare | Biotechnology & Medical Research | €3.44M | €0.52 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Biophytis SA | Paris | Healthcare | Biotechnology & Medical Research | €2.70M | -0x | -0 | €0.13 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Phaxiam Therapeutics | Paris | Healthcare | Biotechnology & Medical Research | €2.22M | €0.22 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Geneuro | Paris | Healthcare | Biotechnology & Medical Research | €2.07M | -0.2x | €0.07 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Coretech 5 | Paris | Healthcare | Biotechnology & Medical Research | €1.07M | €0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Neovacs | Paris | Healthcare | Biotechnology & Medical Research | €5.38K | 0x | €0.003 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |